Zurueck zur Suche

Reporte zur Charge UJ904AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
UT 2 MA 2 NV 2 PA 1 MI 1 OH 1 IL 1 WI 1 CA 1 CO 1 TX 1 NJ 1

VAERS 2486414

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

moderat
Staat
UT
Alter
79,0
Geschlecht
F
Eingang
22.10.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysarthria Feeling abnormal Mobility decreased

Symptomtext

Per the husband, the patient was walking and suddenly said she didn't feel good. Her speech became slurred and she nearly fell down but her husband caught her. He laid her down in bed and she could not move her arms or legs. Her speech remained slurred and gradually improved over the course of about 10 hours. The episode lasted about 10 hours and she feels fine now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
the patient did not seek medical care
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2439004

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

moderat
Staat
UT
Alter
90,0
Geschlecht
M
Eingang
10.09.2022
Impfdatum
07.09.2022
Beginn
08.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Abdominal discomfort Back pain Chest pain Electrocardiogram normal Laboratory test normal Painful respiration

Symptomtext

Pt started feeling an upset stomach the morning after the vaccines (9/8 ~10AM) this then progressed to sharp pains in the chest and back in the evening towards the next morning (9/9). pt stated it hurt when he breathed in so he went to the ER on 9/9 at 3:30 PM and had a full workup to evaluate heart conditions, EKG, checked his a-fib, looked at arteries and everything came back fine. Was told to call the pharmacy to evaluate the possibility of the vaccines since nothing else made sense.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
9/9 in ER per pt- EKG, checked arteries and evaluated Afib Came back normal on all tests
Aktuelle Erkrankungen
none
Vorgeschichte
A-Fib, neuropathy, hypercholesteremia
Andere Medikamente
Multi-vit
Allergien
NKA
Vorherige Impfungen
-

VAERS 2603766

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

mild
Staat
PA
Alter
70,0
Geschlecht
M
Eingang
26.03.2023
Impfdatum
12.10.2022
Beginn
12.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injection site mass Injection site pain Pain

Symptomtext

Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: continued complaint of hard lump at injection site-Medium, Systemic: Joint Pain-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485039

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

mild
Staat
MI
Alter
82,0
Geschlecht
M
Eingang
21.10.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site pruritus

Symptomtext

Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2477013

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

mild
Staat
OH
Alter
90,0
Geschlecht
M
Eingang
13.10.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site bruising

Symptomtext

Site: Bruising at Injection Site-Medium, Systemic: dark bruising from bicep to below elbow, area spreading-Medium, Additional Details: patient presented to the pharmacy on 10/9/22, stating he has had bruising/blood under skin since he received the flu shot on 9/23/22. There was older yellow bruising in the deltoid area and dark skin areas extending from bicep toward elbow and below and patient said the area had been growing since receiving the flu shot. Patient stated he is on eliquis, blood thinner. I advised him to go to ER to have it looked at as he seemed concerned.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475244

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

mild
Staat
MA
Alter
68,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2465947

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

mild
Staat
MA
Alter
66,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
27.09.2022
Beginn
27.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose increased Headache Nausea Retching

Symptomtext

Headache, nausea, dry heaving, high blood glucose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
Blood glucose home test, 9/28/2022, >200
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetes-type 1
Andere Medikamente
Insulin, zoloft, simvastatin, various vitamins, allegra
Allergien
Allergic to codeine
Vorherige Impfungen
Same events, same age

VAERS 2462911

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

mild
Staat
IL
Alter
72,0
Geschlecht
F
Eingang
28.09.2022
Impfdatum
12.09.2022
Beginn
13.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pruritus Injection site rash

Symptomtext

Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Additional Details: Patient came to pharmacy to show us itchy rash/bumps on deltoid area that developed after her flu shot. I counseled her to apply hydrocortisone to relieve the itching. I left a note, and they confirmed she used a 5/8" needle when administering the flu shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2444634

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904AB

mild
Staat
WI
Alter
76,0
Geschlecht
F
Eingang
14.09.2022
Impfdatum
07.09.2022
Beginn
08.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Injection site bruising Injection site erythema Injection site pain Injection site pruritus Injection site swelling Lethargy Rash

Symptomtext

Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Exhaustion / Lethargy-Mild, Additional Details: She came into the pharmacy on 9/10/22 and she still had brusing and swelling was better. She is allergic to latex but has had the vaccine before

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2443941

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

mild
Staat
NV
Alter
68,0
Geschlecht
F
Eingang
13.09.2022
Impfdatum
09.09.2022
Beginn
13.09.2022
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus

Symptomtext

PATIENT PRESENTED WITH REDNESS AND ITCHING AROUND INJECTION SITE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
UNKNOWN
Andere Medikamente
INDAPAMIDE 2.5MG, LACTULOSE 10GM/15ML, METOPROLOL TART 50MG
Allergien
PREDNISONE, PREGABALIN
Vorherige Impfungen
-

VAERS 2440048

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ab

mild
Staat
NV
Alter
67,0
Geschlecht
F
Eingang
10.09.2022
Impfdatum
08.09.2022
Beginn
09.09.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site pain Vaccination site rash Vaccination site warmth

Symptomtext

pt had a rash on left arm that was painful and hot to the touch and expanding on area where vaccines were administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pain
Hospital-Tage
-
Labordaten
I do not know
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension, hypercholesterolemia
Andere Medikamente
Ativan, Losartan, Crestor
Allergien
none
Vorherige Impfungen
-

VAERS 2429008

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

mild
Staat
CA
Alter
74,0
Geschlecht
F
Eingang
05.09.2022
Impfdatum
02.09.2022
Beginn
05.09.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Pruritus Urticaria

Symptomtext

Awoke with 2 inch circular nonpruritic red patch on right biceps. 2 hours later noted 2 separate hives on right arm itching

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None at this time. Await advice. Will take one tablet 25 mgs. Chlorpheniramine antihistamine at 1:00 PM.
Aktuelle Erkrankungen
None
Vorgeschichte
Labile hypertension, hyperlipidemia, keratoconus
Andere Medikamente
Vit.C, Brinzolamide OP, vit.D, CoQ10, Adderall XR, Omega 3, estradiol PO, ketorolac gtt, metoprolol, montelukast, naproxen, simvastatin, Vyzulta gtt, brinzolamide gtt
Allergien
Keflex, compazine, benadryl, erythromycin, biaxin, horseradish, garlic,terragon, cilantro
Vorherige Impfungen
Red patch on arm after pneumonia vaccine

VAERS 2470271

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

gering
Staat
CO
Alter
67,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
03.10.2022
Beginn
04.10.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Peripheral swelling Skin reaction Skin warm

Symptomtext

Within 24 hours, arm was very red, hot to touch, and swollen. Redness was spreading down/around arm, continuing to get worse as time went on. Went to doctor 10/5/22 and was prescribed triamcinolone 0.5% ointment and prednisone 20mg tablets.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Peripheral swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
Hypertension, hypercholesterolemia, anxiety with depression, asthma/COPD
Andere Medikamente
Lisinopril 40mg, levothyroxine 50mcg, wellbutrin XL 150mg, duloxetine 60mg, clopidogrel 75mg, atorvastatin 40mg, metoprolol ER 25mg, methocarbamol 500mg, spiriva respimat 1.25mcg, omeprazole 20mg
Allergien
Cox-2 Inhibitors (celecoxib)
Vorherige Impfungen
-

VAERS 2462876

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

gering
Staat
TX
Alter
51,0
Geschlecht
M
Eingang
28.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

FLUZONE HD was administered to a 51 year old patient with no reported adverse event; Initial information received on 20-Sep-2022 regarding an unsolicited valid non-serious case via health professional and physician. Agency number: 01287082. This case involves a 51-year-old male patient to whom INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ (PCV 20). On 20-Sep-2022, the 51-year patient received suspect FLUZONE HIGH-DOSE QUADRIVALENT at dose 0.7ml once via intramuscular route in the left arm (lot: UJ904AB, expiry: 30-Jun-2023) for immunization with no reported adverse event (product administered to patient of inappropriate age) a same day latency. Action taken: Not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PNEUMOCOCCAL CONJUGATE VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2450427

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

gering
Staat
NJ
Alter
-
Geschlecht
F
Eingang
17.09.2022
Impfdatum
29.08.2022
Beginn
29.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

Fluzone HD was administered but vaccines had been in transit too long and were not suitable for use, administration post excursion with no reported adverse event; Fluzone HD was administered but vaccines had been in transit too long and were not suitable for use, administration post excursion with no reported adverse event; Initial information received on 29-Aug-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 65 years old female patient who was administered Fluzone HD but vaccines had been in transit too long and were not suitable for use, administration post excursion with no reported adverse event, after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 29-Aug-2022, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ904AB and expiration date: 30-Jun-2023) at an unknown dose via unknown route in unknown administration site for immunization. On 29-Aug-2022,the patient developed a non-serious event of fluzone hd was administered but vaccines had been in transit too long and were not suitable for use, administration post excursion with no reported adverse event (poor quality product administered)(latency: same day) (product storage error). Action taken :not applicable. It was not reported if the patient received a corrective treatment for the events Outcome: Unknown for both events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2440289

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AB

gering
Staat
VA
Alter
72,0
Geschlecht
M
Eingang
12.09.2022
Impfdatum
29.08.2022
Beginn
29.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administration error Product storage error

Symptomtext

received a dose of the Fluzone High-Dose Quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event; received a dose of the Fluzone High-Dose Quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event; Initial information received on 30-Aug-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 72 years old male patient who reported received a dose of the fluzone high-dose quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event while receiving vaccine influenza quadrival a-b high dose hv vaccine (Fluzone High-Dose Quadrivalent). Concomitant medications: shingles vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 29-Aug-2022, the patient received a dose of suspect influenza quadrival a-b high dose hv vaccine via prefilled syringe at a dose of 0.7 ml with lot UJ904AB and expiry date: 30-Jun-2023 via intramuscular route in right arm for Immunization. On 29-Aug-2022 (latency: same day) the patient developed a non-serious received a dose of the fluzone high-dose quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event (product storage error) and (product administration error) following the administration of influenza quadrival a-b high dose hv vaccine. Action taken: not applicable Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-